Trial of Indomethacin Prophylaxis in Preterm Infants (TIPP)
Sponsor: Medical Research Council of Canada
A PHASE3 clinical study on Ductus Arteriosus, Patent and Infant, Premature, this trial is completed. The trial is conducted by Medical Research Council of Canada and has accumulated 6 data snapshots since 1993. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Feb 2017 — Jun 2018 [monthly]
Completed PHASE3
▶ Show 1 earlier version
-
Jan 2017 — Feb 2017 [monthly]
Completed PHASE3
First recorded
Nov 1993
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Medical Research Council of Canada
- NICHD Neonatal Research Network
- National Center for Research Resources (NCRR)
For direct contact, visit the study record on ClinicalTrials.gov .